Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Insulin for Neuroprotection in Open Angle Glaucoma
NCT07619482Phase 2Enrolling by invitation
- Sponsor
- Stanford University
- Start
- Sep 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
A Phase 2 trial of EYED-002 in open-angle glaucoma (OAG), sponsored by Stanford University. Started Sep 2026; status: enrolling by invitation.
02
Drugs
EYED-002
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on NCT07619482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07619482.